RJA
TRIL

Raymond James & Associates’s Trillium Therapeutics Inc. TRIL Stock Holding History

Raymond James & Associates’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-42,037
Closed -$738K – 4159
2021
Q3 		$738K Buy
42,037
+6,131
+17% +$108K ﹤0.01% 2771
2021
Q2 		$348K Buy
35,906
+1,424
+4% +$13.8K ﹤0.01% 3312
2021
Q1 		$370K Buy
34,482
+20,885
+154% +$224K ﹤0.01% 3203
2020
Q4 		$200K Buy
+13,597
New +$200K ﹤0.01% 3366